TY  - JOUR 
AU  - Antón Aparicio, Luis Miguel
PY  - 2011
SN  - 1465-6566
UR  - http://hdl.handle.net/20.500.11940/2775
LA  - eng
TI  - Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
T2  - EXPERT OPINION ON PHARMACOTHERAPY
M2  - 2433
VL  - 12
ER  -